Dentine Hypersensitivity Management KAP Study
Launched by MUHAMMAD MODU · Aug 30, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Diagnosis of dentin hypersensitivity is a challenge faced by dentists with different educational levels and the condition might be overlooked and not properly managed leading to persistent pain and poor quality of life for patients. Till the now, literature lacks rigorous guidelines for systematic diagnosis, prevention, categorization of severity and management of dentin hypersensitivity.
This study intends to spot the light on the current approaches adopted by dentists in Egypt and Nigeria towards diagnosis and management of Dentine Hypersensitivity. It also intends to compare the finding...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Must be a Dentist
- • Must be in clinical practice
- • Must be practicing in Egypt or Nigeria
- • Willingly CHOOSE to participate in the study
- Exclusion Criteria:
- • Dentists that choose NOT to participate in the study
About Muhammad Modu
Muhammad Modu is a dedicated clinical trial sponsor committed to advancing medical research and improving patient outcomes through innovative trial designs and robust methodologies. With a focus on developing therapies across various therapeutic areas, the organization emphasizes ethical practices, regulatory compliance, and patient safety. Leveraging a team of experienced professionals, Muhammad Modu fosters collaboration with healthcare providers, research institutions, and regulatory bodies to ensure the successful execution of clinical trials that contribute to the scientific community and enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported